Position in ARQT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,471,611
+$675,365 QoQ
Shares Held
170,542
+5.8% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 271 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. ARQT ranks #56 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in ARQT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,471,611 | 170,542 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,796,246 | 161,131 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,687,114 | 161,402 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,451,981 | 183,129 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,609,107 | 186,099 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,831,997 | 181,074 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $2,340,964 | 168,052 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,520,122 | 163,454 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,555,787 | 167,289 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,242,050 | 125,333 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $345,387 | 106,931 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $421,773 | 79,430 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $748,600 | 78,552 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $595,826 | 54,166 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $789,979 | 53,377 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $853,720 | 44,674 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $881,061 | 41,345 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $680,648 | 35,340 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $738,385 | 35,602 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $850,101 | 35,584 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $935,610 | 34,284 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $582,447 | 20,133 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $565,075 | 20,088 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $497,367 | 16,975 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $333,577 | 11,031 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $294,453 | 9,881 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||